Zobrazeno 1 - 9
of 9
pro vyhledávání: '"John M L Ebos"'
Autor:
Scott I Abrams, Fumito Ito, Yuhao Shi, Melissa Dolan, Jianxin Wang, Xuedan He, Shiqi Zhou, Breandan Quinn, Dushyant Jahagirdar, Wei-Chiao Huang, Moriya Tsuji, Roberto Pili, Joaquin Ortega, John M L Ebos, Jonathan F Lovell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/c3dabdbbc9174f55a2075fc232a9841e
Autor:
Melissa Dolan, Michalis Mastri, Amanda Tracz, James G Christensen, Gurkamal Chatta, John M L Ebos
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220101 (2019)
Tyrosine kinase inhibitors (TKIs) that primarily target angiogenesis are approved to treat several cancers in the metastatic setting; however, resistance is common. Sequential treatment or 'switching' from one TKI to another following failure can be
Externí odkaz:
https://doaj.org/article/f113214fd21848ecb9641a0dcbff504e
Autor:
Sébastien Benzekry, Clare Lamont, Afshin Beheshti, Amanda Tracz, John M L Ebos, Lynn Hlatky, Philip Hahnfeldt
Publikováno v:
PLoS Computational Biology, Vol 10, Iss 8, p e1003800 (2014)
Despite internal complexity, tumor growth kinetics follow relatively simple laws that can be expressed as mathematical models. To explore this further, quantitative analysis of the most classical of these were performed. The models were assessed agai
Externí odkaz:
https://doaj.org/article/19e31e19343449d79eb789570472c361
Autor:
Michalis Mastri, John M. L. Ebos
Publikováno v:
Molecular & Cellular Oncology, Vol 6, Iss 2, Pp 1-3 (2019)
Cancer treatments can induce a form of senescence that halts cellular division while allowing continued secretion of tumor-promoting proteins. We recently found that antiangiogenic treatment resistance can lead to a transient hijacking of the senesce
Externí odkaz:
https://doaj.org/article/f61b3f2b95f24cc4932b1da0d687f336
Autor:
Verónica Torres-Estay, Michalis Mastri, Spencer Rosario, Patricia Fuenzalida, Carolina E. Echeverría, Emilia Flores, Anica Watts, Javier Cerda-Infante, Viviana P. Montecinos, Paula C. Sotomayor, Julio Amigo, Carlos Escudero, Francisco Nualart, John M. L. Ebos, Dominic J. Smiraglia, Alejandro S. Godoy
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4750
The survival of patients with solid tumors, such as prostate cancer (PCa), has been limited and fleeting with anti-angiogenic therapies. It was previously thought that the mechanism by which the vasculature regulates tumor growth was driven by a pass
Autor:
Xuedan, He, Shiqi, Zhou, Melissa, Dolan, Yuhao, Shi, Jianxin, Wang, Breandan, Quinn, Dushyant, Jahagirdar, Wei-Chiao, Huang, Moriya, Tsuji, Roberto, Pili, Fumito, Ito, Joaquin, Ortega, Scott I, Abrams, John M L, Ebos, Jonathan F, Lovell
Publikováno v:
Journal for Immunotherapy of Cancer
Background Induction of CD8+ T cells that recognize immunogenic, mutated protein fragments in the context of major histocompatibility class I (MHC-I) is a pressing challenge for cancer vaccine development. Methods Using the commonly used murine renal
Autor:
Cristina, Vaghi, Anne, Rodallec, Raphaëlle, Fanciullino, Joseph, Ciccolini, Jonathan P, Mochel, Michalis, Mastri, Clair, Poignard, John M L, Ebos, Sébastien, Benzekry
Publikováno v:
PLoS Computational Biology
PLoS Computational Biology, Public Library of Science, 2020, 16 (2), pp.e1007178. ⟨10.1371/journal.pcbi.1007178⟩
PLoS Computational Biology, 2020, 16 (2), pp.e1007178. ⟨10.1371/journal.pcbi.1007178⟩
PLoS Computational Biology, Vol 16, Iss 2, p e1007178 (2020)
PLoS Computational Biology, Public Library of Science, 2020, 16 (2), pp.e1007178. ⟨10.1371/journal.pcbi.1007178⟩
PLoS Computational Biology, 2020, 16 (2), pp.e1007178. ⟨10.1371/journal.pcbi.1007178⟩
PLoS Computational Biology, Vol 16, Iss 2, p e1007178 (2020)
Tumor growth curves are classically modeled by means of ordinary differential equations. In analyzing the Gompertz model several studies have reported a striking correlation between the two parameters of the model, which could be used to reduce the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::67031bb1e42f4b2d69523876fad554dd
https://www.hal.inserm.fr/inserm-02515955/document
https://www.hal.inserm.fr/inserm-02515955/document
Publikováno v:
Current drug targets. 17(15)
Autor:
John M L, Ebos, Jennifer, Tran, Zubin, Master, Daniel, Dumont, Junia V, Melo, Elisabeth, Buchdunger, Robert S, Kerbel
Publikováno v:
Molecular cancer research : MCR. 1(2)
A large and diverse spectrum of oncogenes has been implicated as a contributor to angiogenesis in solid tumors based, in part, on its ability to induce proangiogenic growth factors such as vascular endothelial growth factor (VEGF), and the fact that